Figure 2
From: GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
Correlation of the co-expression of GPR30 and EGFR with the progression-free survival or overall survival. (A) A high level of tumor co-expression of GPR30 and EGFR was significantly associated with a poorer progression-free survival (p<;0.001). (B) There was no significant relationship, but there was a tendency for there to be a correlation between the overall survival and the co-expression of GPR30 and EGFR (P=0.07).